PSIL.US AdvisorShares Psychedelics ETF

ETF AdvisorShares USA Stocks
- USD
No recent price
Total assets
38.1M
Expense ratio
0.99%
Dividend yield
7.99%
1-year return
+6.92%
Holdings
23
Since
2021

Fund data as reported by the issuer, updated Nov 17, 2026. Total assets are in the fund's base currency.

What does PSIL.US invest in?

  • Mostly US stocks (68.9%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (84.9%)
  • Top 3 holdings: 31.4% of the fund

Asset allocation

  • US stocks 68.9%
  • Non-US stocks 29.3%
  • Cash 0.3%

Top holdings

All holdings, sectors and regions

AdvisorShares Psychedelics ETF performance

Sharpe ratio 0.46
This year
+2.61%
1 year
+6.92%
3 years
+14.27%
5 years
-23.71%

Volatility 27.0% over 1 year and 47.0% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

PSIL.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About AdvisorShares Psychedelics ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies…

Full fund profile